Baxter Files Swine Flu Vaccine Patent a Year Ahead of Outbreak --US20090060950A1 to Baxter International filed 28th August 2008 By Lara 10 Jul 2009 Baxter Vaccine Patent Application US 2009/0060950 A1 --'In particular preferred embodiments the composition or vaccine comprises more than one antigen.....such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.'
Comment
Otfried Kistner, the head of virology at Baxter’s Austrian subsidiary in Orth an der Donau, which contaminated 72 kilos of vaccine material with the live bird flu virus and sent it to 16 labs this February, was part of the Austrian-based Baxter team that applied for a provisional patent for the “swine flu” H1N1 vaccine in August 2007, almost two years before the first “swine flu” outbreak in Mexico City in April2009 in a location about 50 kilometers from a Baxter facility.
Baxter’s Vaccine Patent Application US 2009/0060950 A1 gives “Kistner et al” as the applicant for the patent for the H1N1 vaccine that was provisionally filed on August 28, 2007.
Also Kistner is an advisor to WHO and took part in the WHO meeting in Geneva 2005 on the Evaluation and Development of Influenza Pandemic Vaccines.
It was WHO which supplied Baxter with the live bird flu virus that Baxter used to contaminate 72 kilos of vaccine material, sending it to 16 labs in four countries, neary sparking a pandemic in Febuary.
"Destroying the New World Order"
THANK YOU FOR SUPPORTING THE SITE!
© 2024 Created by truth. Powered by
You need to be a member of 12160 Social Network to add comments!
Join 12160 Social Network